1520ai Appoints Tiffany Carpenter As Director Of Sales And Market Development
Healthcare technology sales leader brings more than 15 years of experience across hospice, home health, and post-acute care
DENVER, Colo., [August 24, 2026]: 1520ai, an AI-first healthcare technology company developing intelligence and compliance solutions for hospice providers, today announced the appointment of Tiffany Carpenter as Director of Sales and Market Development.
In this role, Carpenter will lead 1520ai’s enterprise sales and market development efforts, including customer engagement, strategic partnerships, market positioning, and the continued development of the company’s commercial strategy. She will also work closely with 1520ai’s clinical, product, technology, and executive teams to ensure that customer and industry perspectives remain central to the company’s product development and market approach.
Carpenter brings more than 15 years of healthcare technology experience, with a particular focus on hospice, home health, skilled nursing, and other post-acute care settings. Her background includes enterprise sales leadership, strategic business partnerships, SaaS and cloud-based technology, workflow automation, EMR integration, mobile healthcare solutions, and post-acute data analytics.
Her career includes sales leadership positions with BetterRX, Trella Health, and CellTrak Technologies, as well as earlier healthcare solutions and national account roles with Sprint Nextel and USA Mobility. Across these organizations, Carpenter has worked with healthcare providers adopting technology intended to improve access to information, strengthen operational performance, automate workflows, and support better care delivery.
“Tiffany brings a valuable combination of healthcare technology experience, deep knowledge of the post-acute market, and the ability to build trusted enterprise relationships,” said Ernesto Lopez, Founder and CEO of 1520ai. “She understands how hospice leaders evaluate technology, how to connect product capabilities to meaningful operational value, and how to translate customer feedback into stronger solutions. Her leadership will be important as we build our commercial presence and introduce 1520ai’s capabilities to the organizations we are designed to serve.”
“1520ai is addressing challenges that hospice leaders are confronting every day, including regulatory complexity, documentation quality, operational visibility, and the responsible adoption of artificial intelligence,” Carpenter said. “I am pleased to join a team that understands the realities of hospice care and is developing practical solutions around the needs of providers, clinicians, patients, and families.”
Carpenter joins 1520ai as the company advances from product development into broader market engagement. She will help establish the sales infrastructure, strategic relationships, and market feedback channels needed to support responsible and sustainable growth.
About 1520ai
1520ai is an AI-first healthcare technology company focused on hospice regulatory compliance, documentation quality, audit readiness, and operational intelligence. The company is developing hospice-native solutions designed to help organizations identify risk earlier, strengthen regulatory readiness, and convert complex clinical, regulatory, and operational information into actionable insight.
1520ai’s approach emphasizes explainability, healthcare privacy, responsible artificial intelligence, and close collaboration with hospice professionals. The company’s objective is to provide hospice organizations with practical technology that supports stronger decision-making while preserving appropriate clinical judgment and human oversight.